These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16797217)

  • 1. Placing the dynamics of syringe exchange programs in the United States.
    Tempalski B
    Health Place; 2007 Jun; 13(2):417-31. PubMed ID: 16797217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syringe exchange as a social movement: a case study of harm reduction in Oakland, California.
    Bluthenthal RN
    Subst Use Misuse; 1998 Apr; 33(5):1147-71. PubMed ID: 9596381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas.
    Tempalski B; Flom PL; Friedman SR; Des Jarlais DC; Friedman JJ; McKnight C; Friedman R
    Am J Public Health; 2007 Mar; 97(3):437-47. PubMed ID: 17267732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syringe exchange programs --- United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(45):1488-91. PubMed ID: 21085091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to improve access to sterile syringes for injection drug users.
    Rich JD; Wolf FA; Macalino G
    AIDS Read; 2002 Dec; 12(12):527-35. PubMed ID: 12518719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's community got to do with it? Implementation models of syringe exchange programs.
    Downing M; Riess TH; Vernon K; Mulia N; Hollinquest M; McKnight C; Jarlais DC; Edlin BR
    AIDS Educ Prev; 2005 Feb; 17(1):68-78. PubMed ID: 15843111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syringe-exchange programs and HIV prevention: if they're effective, what's the controversy?
    Villarreal H; Fogg C
    Am J Nurs; 2006 May; 106(5):58-63; quiz 63-4. PubMed ID: 16639248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.
    Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
    J Subst Abuse Treat; 2007 Jun; 32(4):423-9. PubMed ID: 17481466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doing harm reduction better: syringe exchange in the United States.
    Des Jarlais DC; McKnight C; Goldblatt C; Purchase D
    Addiction; 2009 Sep; 104(9):1441-6. PubMed ID: 19215605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringe Decriminalization Advocacy in Red States: Lessons from the North Carolina Harm Reduction Coalition.
    Cloud DH; Castillo T; Brinkley-Rubinstein L; Dubey M; Childs R
    Curr HIV/AIDS Rep; 2018 Jun; 15(3):276-282. PubMed ID: 29740734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographic approaches to quantifying the risk environment: drug-related law enforcement and access to syringe exchange programmes.
    Cooper HL; Bossak B; Tempalski B; Des Jarlais DC; Friedman SR
    Int J Drug Policy; 2009 May; 20(3):217-26. PubMed ID: 18963907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs.
    Beletsky L; Grau LE; White E; Bowman S; Heimer R
    Addiction; 2011 Feb; 106(2):357-65. PubMed ID: 21054615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update: syringe-exchange programs--United States, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jun; 46(24):565-8. PubMed ID: 9221326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal injections: the law, science, and politics of syringe access for injection drug users.
    Burris S; Strathdee SA; Vernick JS
    Univ San Francisco Law Rev; 2003; 37(4):813-85. PubMed ID: 15457636
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence, characteristics, and predictors of police training initiatives by US SEPs: building an evidence base for structural interventions.
    Beletsky L; Grau LE; White E; Bowman S; Heimer R
    Drug Alcohol Depend; 2011 Dec; 119(1-2):145-9. PubMed ID: 21705159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misdirected opposition: Evidence opposing "not in my back yard" arguments against syringe exchange programmes.
    Williams CT; Ouellet LJ
    Int J Drug Policy; 2010 Sep; 21(5):437-9. PubMed ID: 20233654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural impediments to operational syringe-exchange programs.
    Heimer R; Bluthenthal RN; Singer M; Khoshnood K
    AIDS Public Policy J; 1996; 11(4):169-84. PubMed ID: 10915251
    [No Abstract]   [Full Text] [Related]  

  • 18. The law (and politics) of safe injection facilities in the United States.
    Beletsky L; Davis CS; Anderson E; Burris S
    Am J Public Health; 2008 Feb; 98(2):231-7. PubMed ID: 18172151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies.
    Kral AH; Anderson R; Flynn NM; Bluthenthal RN
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1307-12. PubMed ID: 15385739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research, politics, and needle exchange.
    Des Jarlais DC
    Am J Public Health; 2000 Sep; 90(9):1392-4. PubMed ID: 10983194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.